Peer Review reports
From: The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
| Original Submission | ||
|---|---|---|
| 4 Sep 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 22 Oct 2022 | Reviewed | Reviewer Report |
| 3 Nov 2022 | Reviewed | Reviewer Report - Venugopal Vangala |
| 17 Nov 2022 | Author responded | Author comments - Yan Sun |
| Resubmission - Version 3 | ||
| 17 Nov 2022 | Submitted | Manuscript version 3 |
| 22 Nov 2022 | Author responded | Author comments - Yan Sun |
| Resubmission - Version 4 | ||
| 22 Nov 2022 | Submitted | Manuscript version 4 |
| 5 Dec 2022 | Reviewed | Reviewer Report - Venugopal Vangala |
| 10 Dec 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 14 Dec 2022 | Editorially accepted | |
| 5 Jan 2023 | Article published | 10.1186/s12885-022-10448-z |
You can find further information about peer review here.